Patient details
| Patient Number | Sex | Age (yr) | Dose | Diagnosis | Concurrent Medication |
|---|---|---|---|---|---|
| mg/m2 | |||||
| 1 | F | 3 | 2000 | RMS | Fluconazole, Mes |
| 2 | M | 3 | 1050 | NB | Fluconazole, Hyd, Mes, Para Prop, Sal |
| 3 | M | 5 | 1050 | NB | Chlorp, Fluconazole, Hyd Imip, Mes |
| 4 | M | 7 | 1050 | NB | Amiloride, Amp, Cef Fluconazole, Mes, Van |
| 5 | M | 7 | 1520 | BMT | Acy, All, Fluconazole, Mes Ran, TS |
| 6 | M | 14 | 1700 | BMT | Acy, All, Fluconazole, Mes, TS |
| 7 | M | 17 | 2130 | BMT | Acy, All, Chlorp Fluconazole, TS |
| 8 | F | 18 | 1000 | BMT | Acy, Fluconazole, Mes Ran, TS |
| 9 | M | 18 | 1050 | NB | Fluconazole, Frus, Mes, Nab Vcr, VP16 |
| 10 | M | 0.17 | 270 | NB | Cisplatin, Frus, Hyd Nifedipine, Para, Prop |
| 11 | M | 0.75 | 1000 | BMT | Busulphan, Cef, Chlorp Hyd, Mes, TS, Van, VP16 |
| 12 | F | 0.75 | 810 | RMS | Frus, Hyd, Imip, Prop TS, VP16 |
| 13 | F | 1 | 1040 | ET | Mes, Vcr, VP16 |
| 14 | F | 1 | 600 | NB | Carb, Vcr, VP16 |
| 15 | M | 2 | 600 | NB | Carb, Vcr, VP16, Imip, Teic |
| 16 | M | 2 | 600 | NB | Frus, Trimethoprim, Carb Vcr, VP16 |
| 17 | F | 3 | 600 | NB | Amoxycillin, Carb, Vcr, VP16 |
| 18 | M | 4 | 560 | OS | Actinomycin D, Bleomycin Metoclopramide, TS |
| 19 | F | 4 | 1050 | NB | Mes, Imip, Vcr, VP16 |
| 20 | F | 5 | 510 | MEC | Doxorubicin |
| 21 | M | 7 | 1070 | RMS | TS, VP16 |
| 22 | M | 17 | 2000 | RMS | Nab, Mes |
BMT, bone marrow transplant; ET, epithelial teratoma; MEC, mucoepidermal carcinoma of the salivary gland; NB, neuroblastoma; OS, osteosarcoma; RMS, rhabdomyosarcoma; Acy, acyclovir; All, allopurinol; Amp, amphotericin; Carb, carboplatin; Cef, ceftazidime; Chlor, chlorpheniramine; Frus, frusemide; Hyd, hydrallazine; Imip, imipenem; Mes, mesna; Nab, nabilone; Para, paracetamol; Prop, propranolol; Ran, ranitidine; Sal, salbutamol (nebulised); Teic, teicoplanin; TS, trimethoprim-sulphamethoxazole; Van, vancomycin; Vcr, vincristine; VP16, etoposide.